Role of CTSA institutes and academic medical centers in facilitating preapproval access to investigational agents and devices during the COVID-19 pandemic

INTRODUCTION: With no approved treatments for COVID-19 initially available, the Food and Drug Administration utilized multiple preapproval pathways to provide access to investigational agents and/or medical devices: Expanded Access, Emergency Use Authorizations, and Clinical Trials. Regulatory units...

Descripción completa

Detalles Bibliográficos
Autores principales: Gravelin, Misty, Wright, Jeanne, Holbein, M.E. Blair, Berro, Marlene, Brown, Jennifer S., Mashour, George A., Weatherwax, Kevin J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134898/
https://www.ncbi.nlm.nih.gov/pubmed/34192051
http://dx.doi.org/10.1017/cts.2021.15

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8134898/
https://www.ncbi.nlm.nih.gov/pubmed/34192051
http://dx.doi.org/10.1017/cts.2021.15

Ejemplares similares